FEMYFemasys Inc. Common Stock

NAS · US · Healthcare · Medical Instruments & Supplies · femasys.com

2.960USD+9.23%Mkt Cap: 24.79M $P/E: —3d ago

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratub…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$135.72BUSDP/E 43.4

EssilorLuxottica Societe anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$52.30BUSDP/E 33.2

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.85BUSDP/E 45.2

DIM

Sartorius Stedim Biotech

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.73BUSDP/E 69.1

SOLV

Solventum Corporation Common Stock

$15.25BUSDP/E 10.9

COO

The Cooper Companies, Inc.

$14.87BUSDP/E 64.6

BAX

Baxter International Inc.

$13.62BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap24.79M $

Enterprise Value11.60M $

Revenue (TTM)2.30M $

Gross Profit1.42M $

Net Income (TTM)-18.63M $

Revenue/Share0.7730 USD

Last Price2.960 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees51

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.28

PEG—

EV/EBITDA-0.67

EV/Revenue5.05

P/S9.94

P/B1.13

EPS (TTM)-2.73

EPS (Forward)-2.13

52W Range

2.0225% of range22.20

52W High22.20 USD

52W Low2.022 USD

Profitability

Gross Margin61.96%

Oper. Margin-1526.66%

EBITDA Margin0.00%

Profit Margin-812.27%

ROE-317.38%

ROA-89.88%

Growth

Revenue Growth-18.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-18.69M $

CapEx (TTM)630.10K $

FCF Margin—

FCF Yield—

Net Debt3.35M $

Net Debt/EBITDA-0.19

Balance Sheet

Debt/Equity0.80

Current Ratio2.14

Quick Ratio0.41

Book Value/Sh2.414 USD

Cash/Share0.4770 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:20

Split DateJun 8, 2026

Analyst Consensus

Rating1.7 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)14.33 USD

Upside (mean)+384.2%

Target Range10.00 USD – 23.00 USD

$10.00+384.2% to mean$23.00

# Analysts3

Ownership

Shares Out.8.38M

Float2.48M

Insiders3.85%

Institutions34.89%

Short Interest

Short Ratio5.5d

Short % Float9.19%

Short % Out.8.77%

Shares Short264.93K

Short (prev mo.)190.23K

Technical

SMA 503.412 (-13.3%)

SMA 2009.528 (-68.9%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)1.35M

Avg Vol (10d)4.08M

Technical Indicators

RSI (14)48.7

MACD-0.3525

MACD Signal-0.4242

MACD Hist.+0.0717

BB Upper3.682 USD

BB Middle2.808 USD

BB Lower1.933 USD

BB Width62.33%

ATR (14)0.4513 USD

Vol Ratio (20d)0.29x